NCT03756311No Longer Available不适用
Expanded Access to NanoPac
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
研究概览
简要总结
NanOlogy may consider offering expanded access to NanoPac for patients who do not meet the enrollment criteria of clinical trials in progress.
研究设计
- 研究类型
- Expanded Access
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
No Longer Available
不适用
Expanded Access to NanoDoceUrogenital NeoplasmsNCT04060628NanOlogy, LLC
Available
不适用
Expanded Access to MepseviiMucopolysaccharidosis VIISly SyndromeMPS VIINCT03775174Ultragenyx Pharmaceutical Inc
Unknown
不适用
Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular System InjuriesNCT03631056Humacyte, Inc.
Available
不适用
Expanded Access to Velmanase AlfaAlpha-MannosidosisNCT04959240Chiesi Farmaceutici S.p.A.
Available
不适用
Expanded Access to TriheptanoinLong Chain Fatty Acid Oxidation DisordersNCT03773770Ultragenyx Pharmaceutical Inc